Barbara Tagliaferri

Medico

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life. Palumbo R, Sottotetti F, Trifirò G,Piazza E, Ferzi A, Gambaro A, Spinapolice GE, Pozzi E, Tagliaferri B, Teragni C, Bernardo A. Drug Design, Development and Therapy. 2015; 9:2189-2199.

Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians. Palumbo R, Sottotetti F, Riccardi A, Teragni C, Pozzi E, Quaquarini E, Tagliaferri B, Bernardo A. Ther Adv Med Oncol. 2013 Nov;5(6):334-50.

Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. Strada MR, Palumbo R, Bernardo A, Riccardi A, Teragni C, Poggi G, Frascaroli M, Amatu A, Montagna B, Sottotetti F, Tagliaferri B, Bernardo G. Clin Breast Cancer. 2012 Feb;12(1):30-9.

Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma. Poggi G, Montagna B, Melchiorre F, Quaretti P, Delmonte A, Riccardi A, Tagliaferri B, Sottotetti F, Di Cesare P, Stella MG, Villani L, Zorzetto M, Greco G, Cornalba G, Bernardo G. Anticancer Res. 2011 Nov;31(11):3927-33.

Acute thrombocytopenia: an unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization. Poggi G, Quaretti P, Montagna B, Sottotetti F, Tagliaferri B, Pozzi E, Amatu A, Pagella C, Bernardo G.Cardiovasc Intervent Radiol. 2011 Feb;34 Suppl 2:S190-4. Epub 2010 Sep 18

Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver.Poggi G, Pozzi E, Riccardi A, Tonini S, Montagna B, Quaretti P, Tagliaferri B, Sottotetti F, Baiardi P, Pagella C, Minoia C, Bernardo G..Anticancer Res. 2010 Dec;30(12):5159-64.

OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. Poggi G, Amatu A, Montagna B, Quaretti P, Minoia C, Sottani C, Villani L, Tagliaferri B, Sottotetti F, Rossi O, Pozzi E, Zappoli F, Riccardi A, Bernardo G. Cardiovasc Intervent Radiol. 2009 Nov;32(6):1187-92.

Treatment of chronic hepatitis C in a patient affected by systemic sclerosis. Poggi G, Villani L, Sottotetti F, Tagliaferri B, Montagna B, Amatu A, Bernardo G. Gastroenterol Res Pract. Epub 2009 Nov 17.

Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors. Poggi G, Quaretti P, Minoia C, Bernardo G, Bonora MR, Gaggeri R, Ronchi A, Saluzzo CM, Azzaretti A, Rodolico G, Montagna M, Amatu A, Teragni C, Palumbo I, Traverso E, Tonini S, Villani L, Scelsi M, Baiardi P, Felisi MG, Sottotetti F, Tagliaferri B, Riccardi A. Anticancer Res. 2008 Nov-Dec;28(6B):3835-42.